A biomedical engineer pivots from human movement to women’s health
Postdoc Shaniel Bowen studies women's sexual anatomy and health while also working to interest young women in STEM careers.
Postdoc Shaniel Bowen studies women's sexual anatomy and health while also working to interest young women in STEM careers.
Graduate student Hammaad Adam is working to increase the supply of organs available for transplants, saving lives and improving health equity.
Immunai’s founders were researchers at MIT when they launched their company to help predict how patients will respond to new treatments.
Most antibiotics target metabolically active bacteria, but with artificial intelligence, researchers can efficiently screen compounds that are lethal to dormant microbes.
The longtime academic leader of the Harvard-MIT Program in Health Sciences and Technology reflects on her time spent guiding students at the intersection of medicine and engineering.
MIT spinout Strand Therapeutics has developed a new class of mRNA molecules that can sense where they are in the body, for more targeted and powerful treatments.
Researchers also found that a variant of the protein is not as protective against the bacteria and increases susceptibility to the disease.
Applied during endoscopic procedures, GastroShield could help prevent complications such as bleeding and leakage from weakened gastrointestinal tissues.
Professor Ernest Fraenkel has decoded fundamental aspects of Huntington’s disease and glioblastoma, and is now using computation to better understand amyotrophic lateral sclerosis.
Stimulating gamma brain waves may protect cancer patients from memory impairment and other cognitive effects of chemotherapy.
MIT.nano Immersion Lab works with AR/VR startup to create transcontinental medical instruction.
Albert Almada PhD ’13 studies the mechanics of how stem cells rebuild tissues. “Digging deep into the science is what MIT taught me,” he says.
Using a machine-learning algorithm, researchers can predict interactions that could interfere with a drug’s effectiveness.
MIT spinout Elicio developed a vaccine based on a lymph node-targeting approach first developed at the Koch Institute. Phase 1 solid tumor clinical trial results are promising so far.
A plastic microfluidic chip can remove some risky cells that could potentially become tumors before they are implanted in a patient.